Abbvie Inc. vs The Ensign Group, Inc.
ABBV vs ENSG — side-by-side comparison from reported financials. ABBV leads 6, ENSG leads 6 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
The Ensign Group, Inc.
ENSG · Healthcare
$171.80+0.18%Solid
| Metric | ABBV | ENSG |
|---|---|---|
| Price | $276.43 | $171.80 |
| Market cap | $488B | $10.0B |
| Revenue (TTM) | $64.4B | $5.49B |
| Revenue growth | +1.8% | +18.7% |
| Net margin | 9.8% | 6.9% |
| Free cash flow | $18.2B | $608M |
| Net cash (debt) | ($56.2B) | ($1.63B) |
| 1-year price return | +19.8% | -2.3% |
| P/E | 77.4 | 26.4 |
| P/E vs own history (cheap-side %) | 23% | 48% |
| Dividend yield | 2.45% | 0.15% |
| Return on equity | 96% | 17% |
| Altman Z-score | 2.33 | 3.00 |
| CV checks passed | 9 of 11 | 11 of 11 |
| Employees | 57,000 | 46,000 |
Full résumé-style profiles: ABBV CV · ENSG CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.